Advanced Medical Optics (EYE) Reports Mixed Q2 Earnings; Lowers FY08 EPS Guidance
More News related to EYE
- Advanced Medical Optics (EYE) Tops Q4 Views
- S&P Announces Changes to US Index: SVR for EYE
- Top 10 News Items 1/12-1/16: BofA Gets More Federal Aid, Reports Q4 Loss, Cuts Dividend; Job's to Take Medical Leave; Citi and Morgan Stanley Combine Brokerage Units
- Unusual 11 Mid-Day Movers 1/12: EYE, ETRM, HOLX, VOXX Higher; SAY, LNY, RUTH, ALD Lower
- Morning Movers 1/12: Advanced Medical Optics (EYE) Surges On Buyout; Harley-Davidson (HOG) Lower on Downgrade
Advanced Medical Optics, Inc. (NYSE: EYE) reports Q2 EPS of $0.24, ex-items, 3 cents lower than the analyst estimate of $0.27. Revenues for the quarter were $320.5 million, versus the consensus of $307.69 million.
Lowers its previously issued FY08 EPS guidance from $1.25-$1.45 to $1.00-$1.15, versus the consensus of $1.20. Sales for FY08 are expected to be in the range of $1.22-$1.24 billion, versus $1.23 billion.
Advanced Medical Optics, Inc. engages in the development, manufacture, and marketing of medical devices for the eyes in the Americas, Europe, Africa, the Middle East, Japan, and Asia Pacific.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
